It’s important to report possible adverse events after medicine authorization. Consequently the benefit-risk ratio of the medicinal products can continuously be evaluated. Healthcare professionals are required to report all possible adverse events via the Federal Agency for Medicines and Health Products or via our contact page.
Federal Agency for Medicines and Health Products
Division Vigilance EUROSTATION II Victor Hortaplein, 40/ 40 B-1060 Brussels Website: www.fagg.be E-mail: firstname.lastname@example.org
Direction de la Santé Division de la Pharmacie et des Médicaments Villa Louvigny – Allée Marconi L-2120 Luxembourg Website: http://www.ms.public.lu/fr/activites/pharmacie-medicament/index.html